Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.
Panés, Julián
Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. [electronic resource] - Journal of Crohn's & colitis Aug 2018 - S633-S640 p. digital
Publication Type: Journal Article; Review
1876-4479
10.1093/ecco-jcc/jjy011 doi
Animals
Antibodies, Monoclonal, Humanized--therapeutic use
Cell Adhesion Molecules
Cell Communication--drug effects
Chemotaxis, Leukocyte--drug effects
Endothelial Cells--physiology
Fingolimod Hydrochloride--therapeutic use
Gastrointestinal Agents--pharmacology
Gastrointestinal Tract--immunology
Humans
Immunoglobulins
Immunosuppressive Agents--therapeutic use
Indans--therapeutic use
Inflammatory Bowel Diseases--drug therapy
Integrins--antagonists & inhibitors
Intercellular Adhesion Molecule-1
Leukocytes--physiology
Lysophospholipids--agonists
Mucoproteins--antagonists & inhibitors
Natalizumab--therapeutic use
Oxadiazoles--therapeutic use
Phosphorothioate Oligonucleotides--therapeutic use
Receptors, Lysosphingolipid--agonists
Sphingosine--agonists
Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. [electronic resource] - Journal of Crohn's & colitis Aug 2018 - S633-S640 p. digital
Publication Type: Journal Article; Review
1876-4479
10.1093/ecco-jcc/jjy011 doi
Animals
Antibodies, Monoclonal, Humanized--therapeutic use
Cell Adhesion Molecules
Cell Communication--drug effects
Chemotaxis, Leukocyte--drug effects
Endothelial Cells--physiology
Fingolimod Hydrochloride--therapeutic use
Gastrointestinal Agents--pharmacology
Gastrointestinal Tract--immunology
Humans
Immunoglobulins
Immunosuppressive Agents--therapeutic use
Indans--therapeutic use
Inflammatory Bowel Diseases--drug therapy
Integrins--antagonists & inhibitors
Intercellular Adhesion Molecule-1
Leukocytes--physiology
Lysophospholipids--agonists
Mucoproteins--antagonists & inhibitors
Natalizumab--therapeutic use
Oxadiazoles--therapeutic use
Phosphorothioate Oligonucleotides--therapeutic use
Receptors, Lysosphingolipid--agonists
Sphingosine--agonists